NCT02655029View on ClinicalTrials.gov

Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination

CompletedOBSERVATIONAL

Enrollment

2,285

Participants

Timeline

Start Date

November 25, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 21, 2016

Conditions

Adherence to Medication RegimeHypertensive Disease

Interventions

DRUG

Perindopril/Indapamide/Amlodipine fixed dose combination

Dose selection is based on investigators management.

Trial Locations (1)

Unknown

Ippokratio University Hospital of Athens, Athens

All Listed Sponsors

lead

Servier Hellas Pharmaceuticals Ltd.

INDUSTRY

NCT02655029 - Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination | Biotech Hunter | Biotech Hunter